The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
3-Year Outcomes of the ULTIMATE Trial Comparing Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation
Open accessAbstract
OBJECTIVES: The aim of this study was to explore the difference in target vessel failure (TVF) 3 years after intravascular ultrasound (IVUS) guidance versus angiographic guidance among all comers undergoing second-generation drug-eluting stent (DES) implantation. BACKGROUND: The multicenter randomized ULTIMATE (Intravascular Ultrasound Guided Drug Eluting Stents Implantation in "All-Comers" Coronary Lesions) trial showed a lower incidence of 1-year TVF after IVUS-guided DES implantation among all comers compared with angiographic guidance. However, the 3-year clinical outcomes of the ULTIMATE trial remain unknown. METHODS: A total of 1,448 all comers undergoing DES implantation who were randomly assigned to either IVUS guidance or angiographic guidance in the ULTIMATE trial were followed for 3 years. The primary endpoint was the risk for TVF at 3 years. The safety endpoint was definite or probable stent thrombosis (ST). RESULTS: At 3 years, TVF occurred in 47 patients (6.6%) in the IVUS-guided group and in 76 patients (10.7%) in the angiography-guided group (p = 0.01), driven mainly by the decrease in clinically driven target vessel revascularization (4.5% vs. 6.9%; p = 0.05). The rate of definite or probable ST was 0.1% in the IVUS-guided group and 1.1% in the angiography-guided group (p = 0.02). Notably, the IVUS-defined optimal procedure was associated with a significant reduction in 3-year TVF relative to that with the suboptimal procedure. CONCLUSIONS: IVUS-guided DES implantation was associated with significantly lower rates of TVF and ST during 3-year follow-up among all comers, particularly those who underwent the IVUS-defined optimal procedure compared with those with angiographic guidance. (Intravascular Ultrasound Guided Drug Eluting Stents Implantation in "All-Comers" Coronary Lesions; NCT02215915).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation
Zhang, J., Gao, X., Kan, J., Ge, Z., Han, L., Lu, S., Tian, N., Lin, S., Lu, Q., Wu, X., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.09.013 · Cited by 665
Self-citationHong, S.-J., Kim, B.-K., Shin, D.-H., Nam, C.-M., Kim, J.-S., Ko, Y.-G., Choi, D., Kang, T.-S., Kang, W.-C., Her, A.-Y., et al. (2015) · JAMA · doi:10.1001/jama.2015.15454 · Cited by 621
Park, S.-J., Kim, Y.-H., Park, D.-W., Lee, S.-W., Kim, W.-J., Suh, J., Yun, S.-C., Lee, C. W., Hong, M.-K., Lee, J.-H., et al. (2009) · Circulation: Cardiovascular Interventions · doi:10.1161/circinterventions.108.799494 · Cited by 522
Effect of Intravascular Ultrasound–Guided Drug-Eluting Stent Implantation
Hong, S.-J., Mintz, G. S., Ahn, C.-M., Kim, J.-S., Kim, B.-K., Ko, Y.-G., Kang, T.-S., Kang, W.-C., Kim, Y. H., Hur, S.-H., et al. (2020) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2019.09.033 · Cited by 294
Choi, K. H., Song, Y. B., Lee, J. M., Lee, S. Y., Park, T. K., Yang, J. H., Choi, J.-H., Choi, S.-H., Gwon, H.-C., & Hahn, J.-Y. (2019) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2019.01.227 · Cited by 179
Long-Term Outcomes of Coronary Stenting With and Without Use of Intravascular Ultrasound
Mentias, A. G., Vaughan‐Sarrazin, M., Saad, M. S., Panaich, S., Kapadia, S. R., Horwitz, P. A., & Girotra, S. R. (2020) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2020.04.052 · Cited by 111
Intravascular Imaging and 12-Month Mortality After Unprotected Left Main Stem PCI
Kinnaird, T. D., Johnson, T., Anderson, R. A., Gallagher, S., Sirker, A., Ludman, P., de Belder, M., Copt, S., Oldroyd, K. G., BANNING, A. P., et al. (2020) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2019.10.007 · Cited by 108
Gao, X., Wang, Z., Wang, F., Gu, Y., Ge, Z., Kong, X., Zuo, G., Zhang, J., & Chen, S. (2019) · International journal of cardiac imaging · doi:10.1007/s10554-019-01555-3 · Cited by 58
Self-citation
Cited by
2023 ESC Guidelines for the management of acute coronary syndromes
Byrne, R. A., Rossello, X., Coughlan, J. J., Barbato, E., Berry, C., Chieffo, A., Claeys, M. J., Dan, G.-A., Dweck, M. R., Galbraith, M., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad191 · Cited by 5,333
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization
Lawton, J. S., Tamis-Holland, J. E., Bangalore, S., Bates, E. R., Beckie, T. M., Bischoff, J. M., Bittl, J. A., Cohen, M. G., DiMaio, J. M., Don, C. W., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.09.006 · Cited by 1,558
Lawton, J. S., Tamis-Holland, J. E., Bangalore, S., Bates, E. R., Beckie, T. M., Bischoff, J. M., Bittl, J. A., Cohen, M. G., DiMaio, J. M., Don, C. W., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001038 · Cited by 829
Rao, S. V., O’Donoghue, M. L., Ruel, M., Rab, T., Tamis-Holland, J. E., Alexander, J. H., Baber, U., Baker, H., Cohen, M. G., Cruz-Ruiz, M., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001309 · Cited by 625
Intravascular Imaging–Guided or Angiography-Guided Complex PCI
Lee, J. M., Choi, K. H., Song, Y. B., Lee, J.-Y., Lee, S.-J., Lee, S. Y., Kim, S. M., Yun, K. H., Cho, J. Y., Kim, C. J., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2216607 · Cited by 572
Metadata
- Authors
- Gao, X.-F., Ge, Z., Kong, X.-Q., Kan, J., Han, L., Lu, S., Tian, N.-L., Lin, S., Lu, Q.-H., Wang, X.-Y., Li, Q.-H., Liu, Z.-Z., Chen, Y., Qian, X.-S., Wang, J., Chai, D.-Y., Chen, C.-H., Pan, T., Ye, F., Zhang, J.-J., & Chen, S.-L.
- Venue
- JACC: Cardiovascular Interventions
- Publisher
- Elsevier BV
- Published
- 2021-02
- Volume
- 14
- Issue
- 3
- Pages
- 247-257
- ISSN
- 1876-7605 (ISSN-L)
- 1936-8798
- OpenAlex
- W3093064810
- Cited by
- 338
- References
- 8
- FWCI
- 29.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.